Sort   by:  
 Page size 
To discover potential plasma biomarkers, we are aiming to explore circulating and tumor-derived proteins related to the efficacy of anti-PD-1 treatment to select the optimal NSCLC patients for immunotherapy via DIA.
ORGANISM(S): Homo Sapiens 
2022-02-07 | PXD031474 |
Sort   by:  
 Page size